| 查看: 314 | 回复: 2 | |||
| 当前主题已经存档。 | |||
tiancai_erbao铁杆木虫 (小有名气)
|
[交流]
偶然发现的真菌导致抗癌新药的诞生
|
||
|
Accidental fungus leads to promising cancer drug WASHINGTON (Reuters) - A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S. researchers reported on Sunday. The drug, called lodamin, was improved in one of the last experiments overseen by Dr. Judah Folkman, a cancer researcher who died in January. Folkman pioneered the idea of angiogenesis therapy -- starving tumors by preventing them from growing blood supplies. Lodamin is an angiogenesis inhibitor that Folkman's team has been working to perfect for 20 years. Writing in the journal Nature Biotechnology, his colleagues say they developed a formulation that works as a pill, without side-effects. They have licensed it to SynDevRx, Inc, a privately held Cambridge, Massachusetts biotechnology company that has recruited several prominent cancer experts to its board. Tests in mice showed it worked against a range of tumors, including breast cancer, neuroblastoma, ovarian cancer, prostate cancer, brain tumors known as glioblastomas and uterine tumors. It helped stop so-called primary tumors and also prevented their spread, Ofra Benny of Children's Hospital Boston and Harvard Medical School and colleagues reported. "Using the oral route of administration, it first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice," they wrote in their report. "Liver metastasis is very common in many tumor types and is often associated with a poor prognosis a"When I looked at the livers of the mice, the treated group was almost clean," Benny said in a statement. "In the control group you couldn't recognize the livers -- they were a mass of tumors." The drug was known experimentally as TNP-470, and was originally isolated from a fungus called Aspergillus fumigatus fresenius. Harvards's Donald Ingber discovered the fungus by accident while trying to grow endothelial cells -- the cells that line blood vessels. The mold affected the cells in a way known to prevent the growth of tiny blood vessels known as capillaries. Ingber and Folkman developed TNP-470 with the help of Takeda Chemical Industries in Japan in 1990. But the drug affected the brain, causing depression, dizziness and other side-effects. It also did not stay in the body long and required constant infusions. The lab dropped it. Efforts to improve it did not work well. Then Benny and colleagues tried nanotechnology, attaching two "pom-pom"-shaped polymers to TNP-470, protecting it from stomach acid. In mice, the altered drug, now named lodamin, went straight to tumor cells and helped suppress melanoma and lung cancer, with no apparent side effects, Benny said. All untreated mice had fluid in the abdominal cavity, and enlarged livers covered with tumors. Mice treated with lodamin had normal-looking livers and spleens, the researchers said. Twenty days after being injected with cancer cells, four out of seven untreated mice had died, while all treated mice were still alive, Benny's team reported. Continued... "I had never expected such a strong effect on these aggressive tumor models," she said. The researchers believe lodamin may also be useful in other diseases marked by abnormal blood vessel growth, such as age-related macular degeneration. |
回复此楼» 猜你喜欢
2026CSC博士，有机化学，有机方法学，不对称催化
已经有0人回复
-
2026博士申请-药物化学方向（小分子化合物合成）
已经有4人回复
-
药理学论文润色/翻译怎么收费?
已经有79人回复
-
大肠杆菌临床分离菌株ETEC菌株求购
已经有5人回复
-
钯碳氢气还原脱cbz产物伯胺出现甲基化。
已经有2人回复
-
求助《化工原理》第四版 柴诚敬、贾绍义 课件
已经有0人回复
-
酯类化合物柱层析极性较大，使用醇类溶剂，怎么避免酯交换
已经有2人回复
-
求助骆广生微化工技术书籍
已经有1人回复
-
求助冯连芳、张才亮的《聚合过程强化技术》
已经有0人回复
-
2026考博
已经有0人回复
yalefield
金虫 (文坛精英)
老汉一枚
- 应助: 129 (高中生)
- 贵宾: 0.17
- 金币: 21238.9
- 散金: 3440
- 红花: 66
- 帖子: 12101
- 在线: 759.1小时
- 虫号: 96063
- 注册: 2005-10-07
- 专业: 高等教育学
- 管辖: 计算模拟
|
（1）这怎么是偶然发现？TNP-470已经研究了二十年了。 （2）这个Lodamin在小木虫上早就帖过了。 http://muchong.com/bbs/viewthread.php?tid=885618 [ Last edited by yalefield on 2008-7-22 at 15:50 ] |
2楼2008-07-22 15:47:30